New AstaReal Astaxanthin Plant Will Double Production Capacity
The company expects the site to start producing AstaReal by summer 2014.
Due to increased demand for its AstaReal astaxanthin brand, Fuji Health Science Inc. (Burlington, NJ) is planning to build a new manufacturing facility in Moses Lake, WA. The company says the plant will more than double AstaReal production by 2015. It expects the site to start producing AstaReal by summer 2014.
The environment in Moses Lake-natural fresh water lakes and a fertile ecosystem-is said to be well suited to AstaReal production. (The firm also recently expanded its AstaReal plant in Sweden.) The company says the new facility will feature environment friendly, pure bioreactor cultivation technology for the freshwater microalga Haematococcus pluvialis.
Demand for natural astaxanthin is on the rise, the company says, estimating that the current global market for the ingredient is $200 million, which is set to grow to $700 million by 2017.
The Nutritional Outlook Podcast Episode 36: Best of the Industry Service Provider, Radicle Science
December 26th 2024Nutritional Outlook's managing editor, Sebastian Krawiec, interviews Radicle Science co-founders, Pelin Thorogood and Jeff Chen, MD. Radicle Science has been selected as this year's Best of the Industry, Service Provider.
